Claire OCT System
Perimeter Medical Imaging Ai, Inc. · Decision date Aug 10, 2026
What did the FDA approve?
FDA records P250008/S001 as a supplement to PMA P250008, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 10, 2026.
FDA approval order statement
Approval for a manufacturing site located at RBC Development, LLC (dba Vantage MedTech / RBC Medical Innovations), located at 17100 W 118th Terrace, Olathe, KS 66061, performing cart assembly, consumable (Specimen Immobilizer) assembly, receiving inspection, and tech services and laboratory functions at this facility.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Aug 10, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P250008/S001
- Regulatory pathway
- PMA supplement
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Product code
- SHH
- Decision code
- APPR
- Decision date
- Aug 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: OCT imaging system with AI/ML software for adjunctive detection of breast cancer.
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Product code
- SHH
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250008. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250008 · Original PMA
Claire OCT System
P250008/S001 received
Application receipt date recorded by FDA.
P250008/S001 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P250008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Claire OCT SystemP250008 | Perimeter Medical Imaging Ai, Inc. | PMA approval | Mar 3, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Perimeter Medical Imaging Ai, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 555 Richmond St. W, Suite 511, Toronto, M5V 3B1
Sources and methodology
- Original FDA record: P250008/S001
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records